Status:
WITHDRAWN
The Effect of Prophylactic Antibiotics on Surgical Site Infection Lower Limb Skin Excisions
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Skin Lesion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The incidence of surgical site infection (SSI) infection in clean dermatologic surgery is very low, between 1-3%. Studies have demonstrated a much higher infection rate in skin excision surgeries in t...
Detailed Description
The majority of skin cancers are treated by surgical excision which is being performed in outpatient and primary care settings. Surgical site infection (SSI) is one of the few complications of this r...
Eligibility Criteria
Inclusion
- Patients presenting for skin excision from the thigh, shin or foot, in the Rambam medical center
Exclusion
- Younger than 18 years old.
- Not capable of providing informed consent.
- Declined to participate.
- Currently taking antibiotics.
- Surgeon feels they are clinically indicated for antibiotic treatment following excision.
- Lesions considered as contaminated/ infected prior to surgery.
- Excision not utilizing primary closure or skin graft.
- Patient unable to return for suture removal.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 27 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03357419
Start Date
March 1 2021
End Date
March 27 2022
Last Update
May 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Plastic Surgery, Rambam Medical Center
Haifa, Israel, 31096